Tickerlog
NASDAQ
$7.69
-46.621
-2.078
Updated Thursday 14th of April 2022 02:36:12 PM

Absci Corporation Common Stock

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
EBITDA $
ROE -46.621
EPS -2.078
Marketcap$672.6M
Free Cash Flow$
Health Care
Biotechnology: Pharmaceutical Preparations

Top gainers today
Top losers today